Literature DB >> 11233918

Anti-CD154 monoclonal antibody and thromboembolism.

L Buhler, I P Alwayn, J Z Appel, S C Robson, D K Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11233918     DOI： 10.1097/00007890-200102150-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  13 in total

1.  CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.

Authors:  Vyacheslav Palchevskiy; Ying Ying Xue; Rita Kern; Stephen S Weigt; Aric L Gregson; Sophie X Song; Michael C Fishbein; Cory M Hogaboam; David M Sayah; Joseph P Lynch; Michael P Keane; David G Brooks; John A Belperio
Journal:  JCI Insight       Date:  2019-05-14

2.  Safe use of anti-CD154 monoclonal antibody in pig islet xenotransplantation in monkeys.

Authors:  Rita Bottino; Michael F Knoll; Joshua Graeme-Wilson; Edwin C Klein; David Ayares; Massimo Trucco; David K C Cooper
Journal:  Xenotransplantation       Date:  2017-01-06       Impact factor: 3.907

3.  Surgical and nonsurgical complications of a pig to baboon heterotopic heart transplantation model.

Authors:  P C Corcoran; K A Horvath; A K Singh; R F Hoyt; M L Thomas; M A Eckhaus; M M Mohiuddin
Journal:  Transplant Proc       Date:  2010 Jul-Aug       Impact factor: 1.066

4.  Anti-CD40 antibody-mediated costimulation blockade promotes long-term survival of deep-lamellar porcine corneal grafts in non-human primates.

Authors:  Jaeyoung Kim; Dong Hyun Kim; Hyuk Jin Choi; Hyun Ju Lee; Hee Jung Kang; Chung-Gyu Park; Eung-Soo Hwang; Mee Kum Kim; Won Ryang Wee
Journal:  Xenotransplantation       Date:  2017-04-10       Impact factor: 3.907

Review 5.  Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.

Authors:  David F Pinelli; Mandy L Ford
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

6.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; David Ayares; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-06       Impact factor: 5.209

Review 7.  Update on CD40 and CD154 blockade in transplant models.

Authors:  Tianshu Zhang; Richard N Pierson; Agnes M Azimzadeh
Journal:  Immunotherapy       Date:  2015-08-13       Impact factor: 4.196

8.  Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; Billeta G T Lewis; Michael Eckhaus; Nicole L Dabkowski; Aaron J Belli; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

9.  Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.

Authors:  Edward Seung; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.

Authors:  Christoph Jochum; Mechthild Beste; Eustacia Zellmer; Scott S Graves; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-02       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.